Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation

Clinical and Experimental Immunology

Volumn 114, Issue 2, 1998, Pages 271-276

  Saurwein Teissl, M ^a   Zisterer, K ^a   Schmitt, T L ^a   Gluck R ^b   Cryz, S ^b   Grubeck Loebenstein, B ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b Berna Biotech AG   (Switzerland)

Author keywords

Cytokines; Dendritic cells; Different vaccines; Immune system; Influenza; T cells

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HEMAGGLUTININ; INFLEXAL BERNA; INFLUENZA VACCINE; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SIALIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLUENZA VACCINATION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CELL DIVISION; CYTOKINES; DENDRITIC CELLS; HLA-DR ANTIGENS; HUMANS; INFLUENZA VACCINES; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, INACTIVATED;

EID: 0031731738     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00714.x     Document Type: Article

References (35)

1. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1993; 4:25-44.
2. Immunization Practices Advisory Committee. 1996. Prevention and control of influenza. Morbid Mortal Wkly Rep 1996; 45:1-24.
3. Couch RB, Kasel JA, Glezen WP et al. Influenza: its control in persons and populations. J Infect Dis 1986; 153:431-40.
4. Wang EEL, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. New Engl J Med 1984; 311:1653-8.
5. Feery BJ, Evered MG, Morrison EM. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J Infect Dis 1979; 139:237.
6. Marks MI. Respiratory viruses in cystic fibrosis. New Engl J Med 1984; 311:1695-6.
7. Beyer WEP, Palache AM, Baljet M et al. Antibody induction by influenza vaccine in the elderly: a review of the literature. Vaccine 1989; 7:303-8.
8. Wortley PM, Farizo KM. Pneumococcal and influenza vaccination levels among HIV-infected adolescents and adults receiving medical care in the United States. Adult and Adolescent Spectrum of HIV Disease Project Group. AIDS 1994; 8:941-4.
9. Gupta RK, Siber GR. Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 1995; 13:1263-76.
10. Monto AS. Influenza vaccines for the elderly. New Engl J Med 1994; 31:807-8.
11. Glück R, Mischler R, Finkel B et al. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994; 344:160-3.
12. Schwab R, Russo C, Weksler ME. Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans. Eur J Immunol 1992; 22:2989-93.
13. McElhaney JE, Meneilly GS, Beattie BL et al. The effect of influenza vaccination on IL-2 production in healthy elderly: implications for current vaccination practices. J Gerontol 1992; 47:3-8.
14. Huang YP, Pechere JC, Michel M et al. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J Immunol 1992; 148:515-22.
15. + CTL response in vitro. J Clin Invest 1996; 98:715-22.
16. + cytolytic T cell responses. J Exp Med 1995; 182:1663-71.
17. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-α. J Exp Med 1994; 179:1109-18.
18. Romani N, Gruner S, Brang D et al. Proliferating of dendritic cell progenitors in human blood. J Exp Med 1994; 180:83-93.
19. Steger MM, Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol 1996; 105:544-50.
20. Schuler G, Thurner B, Romani N. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int Arch Allergy Immunol 1997; 112:317-22.
21. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-96.
22. Romani N, Schuler G. The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system. Springer Semin Immunol 1992; 13:265-79.
23. McWilliam AS, Nelson D, Thomas JA et al. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 1994; 179:1331-6.
24. Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995; 16:2-4.
25. MacPherson GG, Jenkins CD, Stein MJ et al. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 1995; 154:1317-22.
26. Sallusto F, Cella M, Danieli C et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
27. Peters JH, Gieseler R, Thiele B et al. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 1996; 17:273-8.
28. + dendritic cells. Proc Natl Acad Sci USA 1996; 93:2588-92.
29. Hsu FJ, Benike C, Fagnoni F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996; 2:52-58.
30. Young JW, Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 1996; 183:7-11.
31. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10-16.
32. Saurwein-Teissl M. The immune response to influenza vaccines: studies in the elderly and the young. 1998 [Thesis].
33. Schnorr, JJ, Xanthakos S, Keikavoussi P et al. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA 1997; 94:5326-31.
34. Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997; 3:849-54.
35. Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183:1789-96.